Download 
|
< Back |
| 02:18 PM | |
| USFDA inspection at manufacturing facility unit 1 and 2 of InvaGen Pharmaceuticals Inc. (wholly owned subsidiary of the Company) located in Hauppauge, Long Island, New York, USA from 16th October 2023 to 25th October 2023 concluded with zero Form 483 observations. | |
| View all announcements for CIPLA LTD. | Source: BSE India |
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback